Mucoadhesive vaginal tablets as veterinary delivery system for the controlled release of an antimicrobial drug, acriflavine

AAPS PharmSciTech

Volumn 3, Issue 3, 2002, Pages

  Gavini, Elisabetta ^a   Sanna, Vanna ^a   Juliano, Claudia ^a   Bonferoni, Maria Cristina ^b   Giunchedi, Paolo ^a  

^a UNIVERSITY OF SASSARI   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

Acriflavine; Chitosan; Microspheres; Mucoadhesive tablets; Vaginal delivery systems; Veterinary dosage form

Indexed keywords

ACRIFLAVINE; ALGINIC ACID; CARBOXYMETHYLCELLULOSE; CHITOSAN; EXCIPIENT; METHYLCELLULOSE; MICROSPHERE;

ANTIBACTERIAL ACTIVITY; ARTICLE; CHEMICAL COMPOSITION; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENCAPSULATION; ESCHERICHIA COLI; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR WEIGHT; NONHUMAN; PARTICLE SIZE; PSEUDOMONAS AERUGINOSA; SPRAY DRYING; STAPHYLOCOCCUS AUREUS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TABLET FORMULATION;

EID: 23144465315     PISSN: 15309932     EISSN: 15309932     Source Type: Journal    
DOI: 10.1007/BF02830618     Document Type: Article

References (25)

1. Rothen-Weinhold R, Gumy MD. Formulation and technology aspects of controlled drug delivery in animals. Pharm Sci Technol Today. 2000;3:222-231.
2. Vermani K, Garg S. The scope and potential of vaginal drug delivery. Pharm Sci Technol Today. 2000;3:359-364.
3. Robinson JR, Bologna WJ. Vaginal and reproductive system treatments using a bioadhesive polymer. J Control Release. 1994;28:87-94.
4. Brown J, Hooper G, Kenyon CJ, Haines S, Burt J, Humphries JM, Newman SP, Davis SS, Sparrow RA, Wilding IR. Spreading and retention of vaginal formulations in post-menopausal women as assessed by gamma scintigraphy. Pharm Res. 1997;28:1073-1078.
5. Lee JW, Park JH, Robinson JR. Bioadhesive-based dosage forms: the next generation. J Pharm Sci. 2000;89:850-866.
6. Giunchedi P, Juliano C, Gavini E, Cossu M, Sorrenti M. Formulation and in vivo evaluation of chlorhexidine buccal tablets prepared using drug loaded chitosan microspheres. Eur J Pharm & Biopharm. 2002;53(2):233-239.
7. Peh KK, Wong CF. Polymeric films as vehicle f or buccal delivery: swelling, mechanical, and bioadhesive properties. J Pharm Sci. 1999;2:53-61.
8. Parodi B, Russo E, Gatti P, Cafaggi S, Bignardi G. Development and in vitro evaluation of buccoadhesive tablets using a new model substrate for bioadhesion measures: the eggshell membrane. Drug Dev & Ind Pharm. 1999;25:289-295.
9. Ugwoke MI, Exaud S, Van Den Mooter G, Verbeke N, Kinget R. Bioavailability of apomorphine following intranasal administration of mucoadhesive drug delivery systems in rabbits. Eur J Pharm Sci. 1999;9:213-219.
10. Lim ST, Martin GP, Berry DJ, Brown MB. Preparation and evaluation of the in vitro drug release properties and mucoadhesion of novel microspheres of hyaluronic acid and chitosan. J Control Release. 2000;66:281-292.
11. Valenta C, Kast CE, Harich I, Bernkop-Schnurch A. Development and in vitro evaluation of a mucoadhesive vaginal delivery system for progesterone. J Control Release. 2001;77:323-332.
12. Genc L, Oguzlar C, Guler E. Studies on vaginal bioadhesive tablets of acyclovir. Pharmazie. 2000;22:297-299.
13. Ceschel GC, Maffei P, Borgia SL, Rossi S. Development of a mucoadhesive dosage form for vaginal administration. Drug Dev & Ind Pharm. 2001;27:541-547.
14. Lee CH, Chien YW. Development and evaluation of a mucoadhesive drug delivery system for dual-controlled delivery of Nonoxynol-9. J Control Release. 1996;39:93-103.
15. Brannon-Peppas L. Novel vaginal drug release applications. Adv Drug Deliv Rev. 1993;11:169-177.
16. Susan Budavari, ed. The Merck Index. 11th ed. Rahway, NJ: Merck & Co, Inc; 1989:118.
17. Martins NE, Silva MCS, Costa GM, Haddad JPA, Leite RC. Use of acriflavine for treatment of bovine trichomoniasis. Revista Brasileira de Reproducao Animal. 1997;21(2):168-169.
18. Muzzarelli RAA, Baldassare V, Conti F, Gazzanelli G, Vasi V, Ferrara P, Biagini G. The biological activity of chitosan: ultrastructural study. Biomaterials. 1988;8:247-252.
19. Singla AK, Chawla M. Chitosan: some pharmaceutical and biological aspects - an update. J Pharm Pharmacol. 2001;53:1047-1067.
20. Kan TA, Peh KK, Ch'ng HS. Mechanical, bioadhesive strength and biological evaluations of chitosan films for wound dressing. J Pharma Pharmaceut Sci (www.ualberta.ca/~csps.) 2000;3:303-311.
21. Conti B, Giunchedi P, Genta I, Conte U. The preparation and in vitro evaluation of the wound-healing properties of chitosan microspheres. STP Pharma Sci. 2000;10:101-104.
22. Edmundson IC. Advances in Pharmaceutical Sciences. Vol 2. Bean HS, Carless JE, Beckett AH, eds. New York, NY: Academic Press; 1967:95.
23. Thrupp LD. Susceptibility testing of antibiotics in liquid media. In: Antibiotics in Laboratory Medicine. Lorian V,ed. Baltimore, MD: William & Wilkins; 1986:93-150.
24. Ferrari F, Bertoni M, Rossi S, Bonferoni MC, Caramella C, Waring MJ, Aulton ME. Comparative rheo-mechanical and adhesive properties of two hydrocolloid dressings: dependence on the degree of hydration. Drug Dev & Ind Pharm. 1996;22:1223-1230.
25. Macleod GS, Collett JH, Fell JT. The potential use of mixed films of pectin, chitosan and HPMC for bimodal drug release. J Control Release. 1999;58:303-310.